Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway

Background. Previous studies have shown that Ampelopsin has an inhibitory effect on human tumors. However, the effect of Ampelopsin on renal cell carcinoma (RCC) is rarely reported. Therefore, this study aims to explain the role of Ampelopsin in RCC. Methods. Different concentrations of Ampelopsin (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhonghe Zhao, Yan Jiang, Zhongguo Liu, Qingyan Li, Tiantian Gao, Shengxia Zhang
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/83b70937c8ce4a72b2a124764a21f8aa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:83b70937c8ce4a72b2a124764a21f8aa
record_format dspace
spelling oai:doaj.org-article:83b70937c8ce4a72b2a124764a21f8aa2021-11-22T01:11:19ZAmpelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway1741-428810.1155/2021/4650566https://doaj.org/article/83b70937c8ce4a72b2a124764a21f8aa2021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/4650566https://doaj.org/toc/1741-4288Background. Previous studies have shown that Ampelopsin has an inhibitory effect on human tumors. However, the effect of Ampelopsin on renal cell carcinoma (RCC) is rarely reported. Therefore, this study aims to explain the role of Ampelopsin in RCC. Methods. Different concentrations of Ampelopsin (0, 10, 25, 50, and 100 μM) were used to treat 786-O cells. Cell viability was detected by MTT assay, colony formation assay, and flow cytometry assay. Transwell assay and Wound healing assay were used to detect cell migration and invasion. Western blot analysis was applied to detect protein expression. Results. Ampelopsin inhibited cell proliferation and induced apoptosis in RCC. And Ampelopsin can inhibit cell migration and invasion in RCC. All these results changed in a dose-dependent manner. Ampelopsin (100 uM) had the strongest inhibitory effect on cell viability and metastasis. In addition, Ampelopsin negatively regulated the PI3K/AKT signaling pathway in RCC cells. Moreover, Ampelopsin was only cytotoxic to RCC cells. Conclusion. Ampelopsin inhibits cell viability and metastasis in RCC by negatively regulating the PI3K/AKT signaling pathway.Zhonghe ZhaoYan JiangZhongguo LiuQingyan LiTiantian GaoShengxia ZhangHindawi LimitedarticleOther systems of medicineRZ201-999ENEvidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Other systems of medicine
RZ201-999
spellingShingle Other systems of medicine
RZ201-999
Zhonghe Zhao
Yan Jiang
Zhongguo Liu
Qingyan Li
Tiantian Gao
Shengxia Zhang
Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
description Background. Previous studies have shown that Ampelopsin has an inhibitory effect on human tumors. However, the effect of Ampelopsin on renal cell carcinoma (RCC) is rarely reported. Therefore, this study aims to explain the role of Ampelopsin in RCC. Methods. Different concentrations of Ampelopsin (0, 10, 25, 50, and 100 μM) were used to treat 786-O cells. Cell viability was detected by MTT assay, colony formation assay, and flow cytometry assay. Transwell assay and Wound healing assay were used to detect cell migration and invasion. Western blot analysis was applied to detect protein expression. Results. Ampelopsin inhibited cell proliferation and induced apoptosis in RCC. And Ampelopsin can inhibit cell migration and invasion in RCC. All these results changed in a dose-dependent manner. Ampelopsin (100 uM) had the strongest inhibitory effect on cell viability and metastasis. In addition, Ampelopsin negatively regulated the PI3K/AKT signaling pathway in RCC cells. Moreover, Ampelopsin was only cytotoxic to RCC cells. Conclusion. Ampelopsin inhibits cell viability and metastasis in RCC by negatively regulating the PI3K/AKT signaling pathway.
format article
author Zhonghe Zhao
Yan Jiang
Zhongguo Liu
Qingyan Li
Tiantian Gao
Shengxia Zhang
author_facet Zhonghe Zhao
Yan Jiang
Zhongguo Liu
Qingyan Li
Tiantian Gao
Shengxia Zhang
author_sort Zhonghe Zhao
title Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
title_short Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
title_full Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
title_fullStr Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
title_full_unstemmed Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
title_sort ampelopsin inhibits cell viability and metastasis in renal cell carcinoma by negatively regulating the pi3k/akt signaling pathway
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/83b70937c8ce4a72b2a124764a21f8aa
work_keys_str_mv AT zhonghezhao ampelopsininhibitscellviabilityandmetastasisinrenalcellcarcinomabynegativelyregulatingthepi3kaktsignalingpathway
AT yanjiang ampelopsininhibitscellviabilityandmetastasisinrenalcellcarcinomabynegativelyregulatingthepi3kaktsignalingpathway
AT zhongguoliu ampelopsininhibitscellviabilityandmetastasisinrenalcellcarcinomabynegativelyregulatingthepi3kaktsignalingpathway
AT qingyanli ampelopsininhibitscellviabilityandmetastasisinrenalcellcarcinomabynegativelyregulatingthepi3kaktsignalingpathway
AT tiantiangao ampelopsininhibitscellviabilityandmetastasisinrenalcellcarcinomabynegativelyregulatingthepi3kaktsignalingpathway
AT shengxiazhang ampelopsininhibitscellviabilityandmetastasisinrenalcellcarcinomabynegativelyregulatingthepi3kaktsignalingpathway
_version_ 1718418292032405504